Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

(RTTNews) - Healthcare Services Group, Inc. (HCSG) Wednesday announced a sharp decline in fourth-quarter earnings, despite a slight growth in revenues. The quarterly earnings were $11.92 million ...

PARIS -LVMH-owned newspaper group Les Echos-Le Parisien is not party to a lawsuit involving French media against Elon Musk's X that it previously said it would join, according to a court official ...

Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.

As previously stated, at Q3, our guidance incorporates a 400 million to 500 million revenue headwind from the introduction of the IRA. Next slide ... with the Merck announcement yesterday on ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per ...

Workday said on Wednesday it will cut around 1,750 jobs, or 8.5 per cent of its current workforce, as the human capital management firm invests heavily in artificial intelligence to counter a ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

Merck’s 2025 guidance fell short of Wall Street expectations. - Spencer Platt/Getty Images Investors have taken to punishing pharma companies that appear unable to gauge demand for their top ...

Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The pharmaceutical giant’s CEO mentioned this in the Q4 earnings call ...

Merck achieved revenue growth in Q4, but stocks tumbled Tuesday amid news that the company is pausing Gardasil shipments to China. © 2025 Fortune Media IP Limited ...